Pandion Therapeutics snags $80m Series B
Cambridge, Massachusetts-based Pandion Therapeutics Inc, a developer of modular protein therapeutics for autoimmune disease, has raised $80 million in Series B financing.
Cambridge, Massachusetts-based Pandion Therapeutics Inc, a developer of modular protein therapeutics for autoimmune disease, has raised $80 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination
